Literature DB >> 16711024

Expression of Pin1 and Ki67 in cervical cancer and their significance.

Hongyu Li1, Hongling Shen, Qian Xu, Dongrui Deng, Shixuan Wang, Yunping Lu, Ding Ma.   

Abstract

In order to investigate the expression levels of Pin1 mRNA and protein in cervical cancer and its association with Ki67 and their clinical significance, amplification of Pin1 gene was examined by RT-PCR, and the expression of both Pin1 and Ki67 protein was detected by immunohistochemistry in cervical cancer tissues. It was shown that the expression levels of Pin1 were higher in cervical cancer than in normal cervical tissues (P < 0.05). The expression of Pin1 protein was increased progressively along with the disease process from normal cervix to CIN and to cervical cancer (P < 0.05). No significant difference in the Pin1 expression was found between disease stages (FIGO), pathological grades or pelvic lymph node metastasis status (P > 0.05). The expression of Pin1 was significantly higher in adenocarcinoma than in squamous carcinoma of the uterine cervix (P < 0.05). In cervical cancer, the overexpression of Pin1 was positively correlated with that of Ki67 (P < 0.05). These results suggested that the overexpression of Pin1 was closely related with cancer cell proliferation or progression of cervical cancer and contributed to oncogenesis. Pin1 may serve as a potential marker for cervical cancer diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16711024     DOI: 10.1007/bf02828056

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

Authors:  G M Wulf; A Ryo; G G Wulf; S W Lee; T Niu; V Petkova; K P Lu
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function.

Authors:  Pei-Jung Lu; Xiao Zhen Zhou; Yih-Cherng Liou; Joseph P Noel; Kun Ping Lu
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

Review 3.  Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Authors:  Gerburg Wulf; Greg Finn; Futoshi Suizu; Kun Ping Lu
Journal:  Nat Cell Biol       Date:  2005-05       Impact factor: 28.824

Review 4.  Pinning down cell signaling, cancer and Alzheimer's disease.

Authors:  Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2004-04       Impact factor: 13.807

5.  Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.

Authors:  Hitoshi Miyashita; Shiro Mori; Katutoshi Motegi; Manabu Fukumoto; Takafumi Uchida
Journal:  Oncol Rep       Date:  2003 Mar-Apr       Impact factor: 3.906

6.  Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.

Authors:  Akihide Ryo; Yih-Cherng Liou; Kun Ping Lu; Gerburg Wulf
Journal:  J Cell Sci       Date:  2003-03-01       Impact factor: 5.285

7.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Authors:  Gustavo Ayala; Dagong Wang; Gerburg Wulf; Anna Frolov; Rile Li; Janusz Sowadski; Thomas M Wheeler; Kun Ping Lu; Lere Bao
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

8.  Structure of human Ki67 FHA domain and its binding to a phosphoprotein fragment from hNIFK reveal unique recognition sites and new views to the structural basis of FHA domain functions.

Authors:  Hongyuan Li; In Ja L Byeon; Yong Ju; Ming Daw Tsai
Journal:  J Mol Biol       Date:  2004-01-02       Impact factor: 5.469

9.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

  9 in total
  1 in total

1.  Discovery and validation of novel biomarkers for detection of cervical cancer.

Authors:  Zigang Li; Jianhua Chen; Shaobo Zhao; Yajun Li; Jie Zhou; Jianghong Liang; Huifang Tang
Journal:  Cancer Med       Date:  2021-02-23       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.